GSA Capital Partners’s Kura Oncology KURA Stock Holding History

GSA Capital Partners’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Buy	+23,537	New	+$222K	0.02%	1391
2026 Q1	–	Sell	-88,395	Closed	-$918K	–	1968
2025 Q4	$918K	Sell	88,395 -29,195	-25%	-$306K	0.08%	416
2025 Q3	$1.04M	Sell	117,590 -24,346	-17%	-$174K	0.09%	371
2025 Q2	$819K	Buy	141,936 +112,914	+389%	+$692K	0.06%	583
2025 Q1	$192K	Sell	29,022 -60,283	-68%	-$470K	0.02%	1403
2024 Q4	$778K	Buy	+89,305	New	+$1.29M	0.06%	578
2023 Q4	–	Sell	-11,039	Closed	-$101K	–	1727
2023 Q3	$101K	Sell	11,039 -98,156	-90%	-$997K	0.01%	1387
2023 Q2	$1.16M	Buy	+109,195	New	+$1.29M	0.12%	239
2022 Q4	–	Sell	-14,497	Closed	-$198K	–	1689
2022 Q3	$198K	Buy	+14,497	New	+$224K	0.03%	1232
2022 Q1	–	Sell	-12,284	Closed	-$172K	–	1630
2021 Q4	$172K	Buy	+12,284	New	+$199K	0.02%	1249

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

GSA Capital Partners's KURA Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Kura Oncology (KURA) in Q2 2026: 23,537 shares worth $258K. The stake represents 0.02% of the portfolio and ranks #1391 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in KURA as recently as Q4 2025.

GSA Capital Partners first reported a position in KURA in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.16M in Q2 2023. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

GSA Capital Partners held 23,537 shares of Kura Oncology worth $258K as of Q2 2026.
Kura Oncology was a new GSA Capital Partners position in Q2 2026.
Kura Oncology made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1391 holding.
GSA Capital Partners first reported a position in Kura Oncology in Q4 2021 and has held it in 10 quarters since.
GSA Capital Partners's Kura Oncology position peaked at $1.16M in Q2 2023.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.